TVRD
Tvardi Therapeutics
TVRD
TVRD
93 hedge funds and large institutions have $101M invested in Tvardi Therapeutics in 2016 Q1 according to their latest regulatory filings, with 13 funds opening new positions, 35 increasing their positions, 29 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
less call options, than puts
Call options by funds: $ | Put options by funds: $
less funds holding
Funds holding: →
13% less first-time investments, than exits
New positions opened: 13 | Existing positions closed: 15
70% less capital invested
Capital invested by funds: $341M → $101M (-$240M)
Holders
93
Holding in Top 10
2
Calls
$91K
Puts
$98K
Top Buyers
| 1 | +$2.66M | |
| 2 | +$2.49M | |
| 3 | +$2.36M | |
| 4 |
JPMorgan Chase & Co
New York
|
+$1.02M |
| 5 |
ARTA
A.R.T. Advisors
New York
|
+$770K |
Top Sellers
| 1 | -$15.2M | |
| 2 | -$14.2M | |
| 3 | -$8.94M | |
| 4 |
PCA
Private Capital Advisors
Darien,
Connecticut
|
-$4.16M |
| 5 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
-$3.33M |